Indivior PLC (NASDAQ:INDV) Short Interest Up 9.9% in December

Indivior PLC (NASDAQ:INDV - Get Free Report) saw a large increase in short interest in December. As of December 31st, there was short interest totalling 1,220,000 shares, an increase of 9.9% from the December 15th total of 1,110,000 shares. Based on an average daily volume of 1,280,000 shares, the short-interest ratio is presently 1.0 days. Approximately 1.1% of the company's stock are sold short.

Indivior Trading Down 0.1 %

NASDAQ:INDV traded down $0.01 during mid-day trading on Monday, reaching $11.65. The company's stock had a trading volume of 1,060,388 shares, compared to its average volume of 974,047. The stock has a market cap of $1.61 billion, a P/E ratio of -291.18 and a beta of 0.74. The firm's fifty day moving average price is $11.48 and its two-hundred day moving average price is $11.02. Indivior has a 12-month low of $7.33 and a 12-month high of $23.22.

Indivior (NASDAQ:INDV - Get Free Report) last issued its quarterly earnings data on Thursday, October 24th. The company reported $0.54 earnings per share for the quarter, beating analysts' consensus estimates of $0.39 by $0.15. Indivior had a negative net margin of 0.17% and a negative return on equity of 351.08%. The company had revenue of $307.00 million for the quarter, compared to the consensus estimate of $302.25 million. Analysts predict that Indivior will post 1.62 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Craig Hallum cut their price target on shares of Indivior from $20.00 to $16.00 and set a "buy" rating on the stock in a report on Friday, October 11th. Piper Sandler reiterated an "overweight" rating and set a $16.00 target price (up from $15.00) on shares of Indivior in a research note on Friday, October 25th.

Hedge Funds Weigh In On Indivior

Institutional investors and hedge funds have recently modified their holdings of the company. Stifel Financial Corp bought a new position in Indivior in the third quarter worth approximately $100,000. Bank of New York Mellon Corp bought a new position in Indivior in the 2nd quarter worth $188,000. Melqart Asset Management UK Ltd purchased a new position in Indivior during the third quarter valued at $132,000. XTX Topco Ltd bought a new stake in Indivior during the second quarter valued at about $249,000. Finally, Jane Street Group LLC purchased a new stake in Indivior in the third quarter worth about $180,000. 60.33% of the stock is currently owned by hedge funds and other institutional investors.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.